SRINIVASAN NAMALA
Aten Porus Lifesciences: Firm is developing drugs to fight a host of rare diseases globallyTo begin with, the duo decided to focus on Niemann-Pick Type C (NPC) disorder that’s also referred to as Childhood Alzheimer’s.03 Feb, 2017, 12.47 AM IST
Load More